TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Efficacy and Safety of Avutometinib ± Defactinib in Recurrent Low-Grade Serous Ovarian Cancer: Primary Analysis of ENGOT-OV60/GOG-3052/RAMP 201.

Susana N Banerjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.